355 related articles for article (PubMed ID: 19001604)
1. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G-protein signalling expression and function in ovarian cancer cell lines.
Hurst JH; Mendpara N; Hooks SB
Cell Mol Biol Lett; 2009; 14(1):153-74. PubMed ID: 18979070
[TBL] [Abstract][Full Text] [Related]
3. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
4. Differential targeting of lysophosphatidic acid LPA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.
Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H
Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells.
Wang GL; Wen ZQ; Xu WP; Wang ZY; Du XL; Wang F
Croat Med J; 2008 Apr; 49(2):175-81. PubMed ID: 18461672
[TBL] [Abstract][Full Text] [Related]
8. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
[TBL] [Abstract][Full Text] [Related]
9. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells.
Chen RJ; Chen SU; Chou CH; Lin MC
Int J Cancer; 2012 Aug; 131(4):789-802. PubMed ID: 21964883
[TBL] [Abstract][Full Text] [Related]
11. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells.
Shin KJ; Kim YL; Lee S; Kim DK; Ahn C; Chung J; Seong JY; Hwang JI
J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268
[TBL] [Abstract][Full Text] [Related]
13. Expressions of lysophosphatidic acid receptors in the development of human ovarian carcinoma.
Si J; Su Y; Wang Y; Yan YL; Tang YL
Int J Clin Exp Med; 2015; 8(10):17880-90. PubMed ID: 26770382
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA
Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
[TBL] [Abstract][Full Text] [Related]
17. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
[TBL] [Abstract][Full Text] [Related]
18. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA
Ueda N; Minami K; Ishimoto K; Tsujiuchi T
Cell Signal; 2020 May; 69():109551. PubMed ID: 32006610
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
20. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
Yun CC; Sun H; Wang D; Rusovici R; Castleberry A; Hall RA; Shim H
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C2-11. PubMed ID: 15728708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
